TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive NCCR Seeks #380 Mil. Increase For NIC In FY 1994; Calls ‘First Step’ In Reaching Byspass Budget Level February 26, 1993
TCL Archive Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors October 31, 2014
